Shareholder Information
Share management and Shareholder Meeting information
Investors
Annual Report and Accounts 2023
March 13 2024
Results, Reports and Presentations
-
Annual Report and Accounts 2023
March 13 2024 Download (15.6MB) -
FY 2023 Financial Results
February 22 2024 Download (628KB) -
Q3 2023 Financial Results
November 9 2023 Download (651KB) -
Q2/H1 2023 Financial Results
July 27 2023 Download (650KB) -
2023 Jefferies Healthcare Conference
June 7 2023 Download (669KB)
Latest News
-
Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone
March 11 2024 -
Court Provides Final Approval of Settlement with Direct Purchaser Class in the Multidistrict Antitrust Litigation; Final Court Approval Concludes the Antitrust Multidistrict Litigation
February 29 2024 -
Indivior Announces Q4 / FY 2023 Financial Results
February 22 2024 -
Indivior Settles Patent Dispute with Teva Subsidiary Actavis
December 20 2023 -
Indivior Prevails in Striking Representative Claims from UK Shareholder Action
December 5 2023
.png)
.png)